Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID Reference, 4th edition, 372 pages

+ the daily Top 10

  Alzheimer's Disease

  Free Subscription

Articles published in Alzheimers Dement

Retrieve available abstracts of 292 articles:
HTML format

Single Articles

    June 2020
  1. CASELLI RJ, Knopman DS, Bu G
    An agnostic reevaluation of the amyloid cascade hypothesis of Alzheimer's disease pathogenesis: The role of APP homeostasis.
    Alzheimers Dement. 2020 Jun 26. doi: 10.1002/alz.12124.
    PubMed     Abstract available

  2. LUTZ MW, Luo S, Williamson DE, Chiba-Falek O, et al
    Shared genetic etiology underlying late-onset Alzheimer's disease and posttraumatic stress syndrome.
    Alzheimers Dement. 2020 Jun 26. doi: 10.1002/alz.12128.
    PubMed     Abstract available

  3. EREN E, Hunt JFV, Shardell M, Chawla S, et al
    Extracellular vesicle biomarkers of Alzheimer's disease associated with sub-clinical cognitive decline in late middle age.
    Alzheimers Dement. 2020 Jun 26. doi: 10.1002/alz.12130.
    PubMed     Abstract available

  4. New Thinking About Thinking, Part 3. Advice on preparing a successful manuscript for Alzheimer's & Dementia.
    Alzheimers Dement. 2020 Jun 24. doi: 10.1002/alz.12141.

  5. MILA-ALOMA M, Salvado G, Gispert JD, Vilor-Tejedor N, et al
    Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer's continuum.
    Alzheimers Dement. 2020 Jun 23. doi: 10.1002/alz.12131.
    PubMed     Abstract available

  6. SHERVA R, Gross A, Mukherjee S, Koesterer R, et al
    Genome-wide association study of rate of cognitive decline in Alzheimer's disease patients identifies novel genes and pathways.
    Alzheimers Dement. 2020 Jun 23. doi: 10.1002/alz.12106.
    PubMed     Abstract available

  7. AZAR M, Chapman S, Gu Y, Leverenz JB, et al
    Cognitive tests aid in clinical differentiation of Alzheimer's disease versus Alzheimer's disease with Lewy body disease: Evidence from a pathological study.
    Alzheimers Dement. 2020 Jun 19. doi: 10.1002/alz.12120.
    PubMed     Abstract available

  8. SNYDER HM, Bain LJ, Brickman AM, Carrillo MC, et al
    Further understanding the connection between Alzheimer's disease and Down syndrome.
    Alzheimers Dement. 2020 Jun 16. doi: 10.1002/alz.12112.
    PubMed     Abstract available

  9. SWERDLOW RH, Hui D, Chalise P, Sharma P, et al
    Exploratory analysis of mtDNA haplogroups in two Alzheimer's longitudinal cohorts.
    Alzheimers Dement. 2020 Jun 16. doi: 10.1002/alz.12119.
    PubMed     Abstract available

  10. COCROFT S, Welsh-Bohmer KA, Plassman BL, Chanti-Ketterl M, et al
    Racially diverse participant registries to facilitate the recruitment of African Americans into presymptomatic Alzheimer's disease studies.
    Alzheimers Dement. 2020 Jun 16. doi: 10.1002/alz.12048.
    PubMed     Abstract available

  11. BERMEJO-PAREJA F, Del Ser T, Valenti M, de la Fuente M, et al
    Salivary lactoferrin as biomarker for Alzheimer's disease: Brain-immunity interactions.
    Alzheimers Dement. 2020 Jun 16. doi: 10.1002/alz.12107.
    PubMed     Abstract available

  12. BI D, Wen L, Wu Z, Shen Y, et al
    GABAergic dysfunction in excitatory and inhibitory (E/I) imbalance drives the pathogenesis of Alzheimer's disease.
    Alzheimers Dement. 2020 Jun 16. doi: 10.1002/alz.12088.
    PubMed     Abstract available

  13. GENTREAU M, Chuy V, Feart C, Samieri C, et al
    Refined carbohydrate-rich diet is associated with long-term risk of dementia and Alzheimer's disease in apolipoprotein E epsilon4 allele carriers.
    Alzheimers Dement. 2020 Jun 7. doi: 10.1002/alz.12114.
    PubMed     Abstract available

  14. FIRTH NC, Primativo S, Brotherhood E, Young AL, et al
    Sequences of cognitive decline in typical Alzheimer's disease and posterior cortical atrophy estimated using a novel event-based model of disease progression.
    Alzheimers Dement. 2020 Jun 2. doi: 10.1002/alz.12083.
    PubMed     Abstract available

    May 2020
  15. ORDING AG, Horvath-Puho E, Veres K, Glymour MM, et al
    Cancer and risk of Alzheimer's disease: Small association in a nationwide cohort study.
    Alzheimers Dement. 2020 May 20. doi: 10.1002/alz.12090.
    PubMed     Abstract available

  16. KNOPMAN D, Lemere CA, Lamb BT, Craft S, et al
    Scientific Advising and Reviewing: On strengthening the bond between the Alzheimer's Association and the scientific community.
    Alzheimers Dement. 2020 May 19. doi: 10.1002/alz.12059.
    PubMed     Abstract available

  17. RIOS-ROMENETS S, Lopera F, Sink KM, Hu N, et al
    Baseline demographic, clinical, and cognitive characteristics of the Alzheimer's Prevention Initiative (API) Autosomal-Dominant Alzheimer's Disease Colombia Trial.
    Alzheimers Dement. 2020 May 17. doi: 10.1002/alz.12109.
    PubMed     Abstract available

  18. MECCA AP, Chen MK, O'Dell RS, Naganawa M, et al
    In vivo measurement of widespread synaptic loss in Alzheimer's disease with SV2A PET.
    Alzheimers Dement. 2020 May 13. doi: 10.1002/alz.12097.
    PubMed     Abstract available

  19. MOORE EE, Gifford KA, Khan OA, Liu D, et al
    Cerebrospinal fluid biomarkers of neurodegeneration, synaptic dysfunction, and axonal injury relate to atrophy in structural brain regions specific to Alzheimer's disease.
    Alzheimers Dement. 2020 May 6. doi: 10.1002/alz.12087.
    PubMed     Abstract available

  20. RENTZ DM, Wessels AM, Bain LJ, Weber CJ, et al
    Clinical meaningfulness addressed at Alzheimer's Association Research Roundtable.
    Alzheimers Dement. 2020;16:814.

    April 2020
  21. JORGENSEN IF, Aguayo-Orozco A, Lademann M, Brunak S, et al
    Age-stratified longitudinal study of Alzheimer's and vascular dementia patients.
    Alzheimers Dement. 2020 Apr 27. doi: 10.1002/alz.12091.
    PubMed     Abstract available

  22. DE FLORES R, Wisse LEM, Das SR, Xie L, et al
    Contribution of mixed pathology to medial temporal lobe atrophy in Alzheimer's disease.
    Alzheimers Dement. 2020 Apr 22. doi: 10.1002/alz.12079.
    PubMed     Abstract available

  23. MURAOKA S, DeLeo AM, Sethi MK, Yukawa-Takamatsu K, et al
    Proteomic and biological profiling of extracellular vesicles from Alzheimer's disease human brain tissues.
    Alzheimers Dement. 2020 Apr 17. doi: 10.1002/alz.12089.
    PubMed     Abstract available

  24. TRARES K, Gao X, Perna L, Rujescu D, et al
    Associations of urinary 8-iso-prostaglandin F2alpha levels with all-cause dementia, Alzheimer's disease, and vascular dementia incidence: results from a prospective cohort study.
    Alzheimers Dement. 2020 Apr 12. doi: 10.1002/alz.12081.
    PubMed     Abstract available

  25. LOPES ALVES I, Collij LE, Altomare D, Frisoni GB, et al
    Quantitative amyloid PET in Alzheimer's disease: the AMYPAD prognostic and natural history study.
    Alzheimers Dement. 2020 Apr 12. doi: 10.1002/alz.12069.
    PubMed     Abstract available

  26. DONOHUE MC, Model F, Delmar P, Volye N, et al
    Initiation of symptomatic medication in Alzheimer's disease clinical trials: Hypothetical versus treatment policy approach.
    Alzheimers Dement. 2020 Apr 8. doi: 10.1002/alz.12058.
    PubMed     Abstract available

  27. GEERTS H, Spiros A
    Learning from amyloid trials in Alzheimer's disease. A virtual patient analysis using a quantitative systems pharmacology approach.
    Alzheimers Dement. 2020 Apr 7. doi: 10.1002/alz.12082.
    PubMed     Abstract available

    March 2020

  28. Alzheimer's Disease Research Enterprise in the Era of COVID-19/SARS-CoV-2.
    Alzheimers Dement. 2020 Mar 22. doi: 10.1002/alz.12093.

  29. 2020 Alzheimer's disease facts and figures.
    Alzheimers Dement. 2020 Mar 10. doi: 10.1002/alz.12068.
    PubMed     Abstract available

  30. JANSSEN O, Vos SJB, Garcia-Negredo G, Tochel C, et al
    Real-world evidence in Alzheimer's disease: The ROADMAP Data Cube.
    Alzheimers Dement. 2020;16:461-471.
    PubMed     Abstract available

    February 2020
  31. XIONG C, Luo J, Coble D, Agboola F, et al
    Complex interactions underlie racial disparity in the risk of developing Alzheimer's disease dementia.
    Alzheimers Dement. 2020 Feb 17. doi: 10.1002/alz.12060.
    PubMed     Abstract available

  32. SCHAFFERT J, LoBue C, White CL 3rd, Wilmoth K, et al
    Risk factors for earlier dementia onset in autopsy-confirmed Alzheimer's disease, mixed Alzheimer's with Lewy bodies, and pure Lewy body disease.
    Alzheimers Dement. 2020 Feb 11. doi: 10.1002/alz.12049.
    PubMed     Abstract available

  33. FRANZMEIER N, Koutsouleris N, Benzinger T, Goate A, et al
    Predicting sporadic Alzheimer's disease progression via inherited Alzheimer's disease-informed machine-learning.
    Alzheimers Dement. 2020 Feb 11. doi: 10.1002/alz.12032.
    PubMed     Abstract available

  34. Bill Gates funds $10 million grant to Alzheimer's Association to fuel research for Alzheimer's treatment.
    Alzheimers Dement. 2020;16:384.

    January 2020
  35. HERRING WJ, Ceesay P, Snyder E, Bliwise D, et al
    Polysomnographic assessment of suvorexant in patients with probable Alzheimer's disease dementia and insomnia: a randomized trial.
    Alzheimers Dement. 2020 Jan 15. doi: 10.1002/alz.12035.
    PubMed     Abstract available

  36. JIA L, Fu Y, Shen L, Zhang H, et al
    PSEN1, PSEN2, and APP mutations in 404 Chinese pedigrees with familial Alzheimer's disease.
    Alzheimers Dement. 2020;16:178-191.
    PubMed     Abstract available

  37. SNYDER PJ, Snyder HM, Bain LJ
    Retinal imaging think tank convened by the Alzheimer's Association to examine its promise in the early detection of Alzheimer's.
    Alzheimers Dement. 2020;16:244.

  38. ALBER J, Goldfarb D, Thompson LI, Arthur E, et al
    Developing retinal biomarkers for the earliest stages of Alzheimer's disease: What we know, what we don't, and how to move forward.
    Alzheimers Dement. 2020;16:229-243.
    PubMed     Abstract available

  39. PATHAK GA, Zhou Z, Silzer TK, Barber RC, et al
    Two-stage Bayesian GWAS of 9576 individuals identifies SNP regions that are targeted by miRNAs inversely expressed in Alzheimer's and cancer.
    Alzheimers Dement. 2020;16:162-177.
    PubMed     Abstract available

  40. ASCHENBRENNER AJ, James BD, McDade E, Wang G, et al
    Awareness of genetic risk in the Dominantly Inherited Alzheimer Network (DIAN).
    Alzheimers Dement. 2020;16:219-228.
    PubMed     Abstract available

  41. LINARD M, Letenneur L, Garrigue I, Doize A, et al
    Interaction between APOE4 and herpes simplex virus type 1 in Alzheimer's disease.
    Alzheimers Dement. 2020;16:200-208.
    PubMed     Abstract available

    December 2019
  42. ELAHI FM, Casaletto KB, La Joie R, Walters SM, et al
    Plasma biomarkers of astrocytic and neuronal dysfunction in early- and late-onset Alzheimer's disease.
    Alzheimers Dement. 2019 Dec 23. pii: S1552-5260(19)35373.
    PubMed     Abstract available

  43. SABBAGH M, Sadowsky C, Tousi B, Agronin ME, et al
    Effects of a combined transcranial magnetic stimulation (TMS) and cognitive training intervention in patients with Alzheimer's disease.
    Alzheimers Dement. 2019 Dec 23. pii: S1552-5260(19)35367.
    PubMed     Abstract available

    November 2019
  44. JANSSEN O, Vos SJB, Garcia-Negredo G, Tochel C, et al
    Real-world evidence in Alzheimer's disease: The ROADMAP Data Cube.
    Alzheimers Dement. 2019 Nov 27. pii: S1552-5260(19)35487.
    PubMed     Abstract available

  45. ANDREWS SJ, Goate A, Anstey KJ
    Association between alcohol consumption and Alzheimer's disease: A Mendelian randomization study.
    Alzheimers Dement. 2019 Nov 27. pii: S1552-5260(19)35486.
    PubMed     Abstract available

  46. GONZALEZ HM, Tarraf W, Fornage M, Gonzalez KA, et al
    A research framework for cognitive aging and Alzheimer's disease among diverse US Latinos: Design and implementation of the Hispanic Community Health Study/Study of Latinos-Investigation of Neurocognitive Aging (SOL-INCA).
    Alzheimers Dement. 2019 Nov 20. pii: S1552-5260(19)35362.
    PubMed     Abstract available

  47. TOLAR M, Abushakra S, Sabbagh M
    The path forward in Alzheimer's disease therapeutics: Reevaluating the amyloid cascade hypothesis.
    Alzheimers Dement. 2019 Nov 4. pii: S1552-5260(19)35450.
    PubMed     Abstract available

  48. Corrigendum to "AMYPAD Diagnostic and Patient Management Study: Rationale and design" [Alzheimer's & Dementia 2019;15:388-99].
    Alzheimers Dement. 2019;15:1505.

    October 2019
  49. ISAACSON RS, Hristov H, Saif N, Hackett K, et al
    Individualized clinical management of patients at risk for Alzheimer's dementia.
    Alzheimers Dement. 2019 Oct 31. pii: S1552-5260(19)35368.
    PubMed     Abstract available

  50. PULINA MV, Hopkins M, Haroutunian V, Greengard P, et al
    C99 selectively accumulates in vulnerable neurons in Alzheimer's disease.
    Alzheimers Dement. 2019 Oct 30. pii: S1552-5260(19)35370.
    PubMed     Abstract available

  51. OSSENKOPPELE R, Lyoo CH, Sudre CH, van Westen D, et al
    Distinct tau PET patterns in atrophy-defined subtypes of Alzheimer's disease.
    Alzheimers Dement. 2019 Oct 28. pii: S1552-5260(19)35375.
    PubMed     Abstract available

  52. BROSSERON F, Kolbe CC, Santarelli F, Carvalho S, et al
    Multicenter Alzheimer's and Parkinson's disease immune biomarker verification study.
    Alzheimers Dement. 2019 Oct 17. pii: S1552-5260(19)35352.
    PubMed     Abstract available

  53. STOCKER H, Nabers A, Perna L, Mollers T, et al
    Prediction of Alzheimer's disease diagnosis within 14 years through Abeta misfolding in blood plasma compared to APOE4 status, and other risk factors.
    Alzheimers Dement. 2019 Oct 11. pii: S1552-5260(19)35349.
    PubMed     Abstract available

  54. GLEASON CE, Norton D, Zuelsdorff M, Benton SF, et al
    Association between enrollment factors and incident cognitive impairment in Blacks and Whites: Data from the Alzheimer's Disease Center.
    Alzheimers Dement. 2019 Oct 6. pii: S1552-5260(19)35138.
    PubMed     Abstract available

  55. OGINO E, Manly JJ, Schupf N, Mayeux R, et al
    Current and past leisure time physical activity in relation to risk of Alzheimer's disease in older adults.
    Alzheimers Dement. 2019 Oct 3. pii: S1552-5260(19)35136.
    PubMed     Abstract available

  56. EHRHARDT S, Porsteinsson AP, Munro CA, Rosenberg PB, et al
    Escitalopram for agitation in Alzheimer's disease (S-CitAD): Methods and design of an investigator-initiated, randomized, controlled, multicenter clinical trial.
    Alzheimers Dement. 2019 Oct 3. pii: S1552-5260(19)35112.
    PubMed     Abstract available

    September 2019
  57. MCRAE-MCKEE K, Udeh-Momoh CT, Price G, Bajaj S, et al
    Perspective: Clinical relevance of the dichotomous classification of Alzheimer's disease biomarkers: Should there be a "gray zone"?
    Alzheimers Dement. 2019 Sep 26. pii: S1552-5260(19)35133.
    PubMed     Abstract available

  58. BLUE EE, Horimoto ARVR, Mukherjee S, Wijsman EM, et al
    Local ancestry at APOE modifies Alzheimer's disease risk in Caribbean Hispanics.
    Alzheimers Dement. 2019 Sep 25. pii: S1552-5260(19)35348.
    PubMed     Abstract available

  59. SCHAEFER KR, Noonan C, Mosley M, Smith J, et al
    Differences in service utilization at an urban tribal health organization before and after Alzheimer's disease or related dementia diagnosis: A cohort study.
    Alzheimers Dement. 2019 Sep 20. pii: S1552-5260(19)35111.
    PubMed     Abstract available

  60. HUQ AJ, Fransquet P, Laws SM, Ryan J, et al
    Genetic resilience to Alzheimer's disease in APOE epsilon4 homozygotes: A systematic review.
    Alzheimers Dement. 2019 Sep 7. pii: S1552-5260(19)30152.
    PubMed     Abstract available

  61. XIONG C, Luo J, Agboola F, Li Y, et al
    A harmonized longitudinal biomarkers and cognition database for assessing the natural history of preclinical Alzheimer's disease from young adulthood and for designing prevention trials.
    Alzheimers Dement. 2019 Sep 7. pii: S1552-5260(19)35122.
    PubMed     Abstract available

  62. THOMAS KR, Edmonds EC, Eppig JS, Wong CG, et al
    MCI-to-normal reversion using neuropsychological criteria in the Alzheimer's Disease Neuroimaging Initiative.
    Alzheimers Dement. 2019 Sep 5. pii: S1552-5260(19)35115.
    PubMed     Abstract available

  63. TAKOUSIS P, Sadlon A, Schulz J, Wohlers I, et al
    Differential expression of microRNAs in Alzheimer's disease brain, blood, and cerebrospinal fluid.
    Alzheimers Dement. 2019 Sep 5. pii: S1552-5260(19)35119.
    PubMed     Abstract available

  64. FINCH CE, Kulminski AM
    The Alzheimer's Disease Exposome.
    Alzheimers Dement. 2019 Sep 3. pii: S1552-5260(19)34079.
    PubMed     Abstract available

    August 2019
  65. MC ARDLE R, Galna B, Donaghy P, Thomas A, et al
    Do Alzheimer's and Lewy body disease have discrete pathological signatures of gait?
    Alzheimers Dement. 2019 Aug 30. pii: S1552-5260(19)35120.
    PubMed     Abstract available

  66. STARTIN CM, Hamburg S, Hithersay R, Al-Janabi T, et al
    Reply to "Down Syndrome Cognitive Marker's Significance in Alzheimer's Disease and Dementia Management".
    Alzheimers Dement. 2019 Aug 23. pii: S1552-5260(19)30138.

  67. LI B, He Y, Ma J, Huang P, et al
    Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota.
    Alzheimers Dement. 2019 Aug 13. pii: S1552-5260(19)35123.
    PubMed     Abstract available

  68. MORENO-GRAU S, de Rojas I, Hernandez I, Quintela I, et al
    Genome-wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks: The GR@ACE project.
    Alzheimers Dement. 2019 Aug 13. pii: S1552-5260(19)35117.
    PubMed     Abstract available

  69. OTTOY J, Verhaeghe J, Niemantsverdriet E, De Roeck E, et al
    (18)F-FDG PET, the early phases and the delivery rate of (18)F-AV45 PET as proxies of cerebral blood flow in Alzheimer's disease: Validation against (15)O-H2O PET.
    Alzheimers Dement. 2019 Aug 9. pii: S1552-5260(19)30151.
    PubMed     Abstract available

    Traumatic brain injury and Alzheimer's disease neuropathology.
    Alzheimers Dement. 2019 Aug 8. pii: S1552-5260(19)34082.

  71. GREEN C, Handels R, Gustavsson A, Wimo A, et al
    Assessing cost-effectiveness of early intervention in Alzheimer's disease: An open-source modeling framework.
    Alzheimers Dement. 2019 Aug 8. pii: S1552-5260(19)30139.
    PubMed     Abstract available

  72. OH J, Eser RA, Ehrenberg AJ, Morales D, et al
    Profound degeneration of wake-promoting neurons in Alzheimer's disease.
    Alzheimers Dement. 2019 Aug 8. pii: S1552-5260(19)34081.
    PubMed     Abstract available

  73. SAKAE N, Josephs KA, Litvan I, Murray ME, et al
    Clinicopathologic subtype of Alzheimer's disease presenting as corticobasal syndrome.
    Alzheimers Dement. 2019 Aug 6. pii: S1552-5260(19)30115.
    PubMed     Abstract available

  74. YU JT, Li JQ, Suckling J, Feng L, et al
    Frequency and longitudinal clinical outcomes of Alzheimer's AT(N) biomarker profiles: A longitudinal study.
    Alzheimers Dement. 2019 Aug 6. pii: S1552-5260(19)30147.
    PubMed     Abstract available

  75. BOS I, Vos SJB, Schindler SE, Hassenstab J, et al
    Vascular risk factors are associated with longitudinal changes in cerebrospinal fluid tau markers and cognition in preclinical Alzheimer's disease.
    Alzheimers Dement. 2019 Aug 1. pii: S1552-5260(19)30122.
    PubMed     Abstract available

  76. MAHLA RS
    Down syndrome cognitive marker's significance in Alzheimer's disease and dementia management.
    Alzheimers Dement. 2019;15:1117-1118.

  77. ELDADAH BA, Fazio EM, McLinden KA
    Lucidity in dementia: A perspective from the NIA.
    Alzheimers Dement. 2019;15:1104-1106.
    PubMed     Abstract available

    July 2019
  78. FILSHTEIN TJ, Brenowitz WD, Mayeda ER, Hohman TJ, et al
    Reserve and Alzheimer's disease genetic risk: Effects on hospitalization and mortality.
    Alzheimers Dement. 2019;15:907-916.
    PubMed     Abstract available

    June 2019
  79. LUTZ MW, Sprague D, Chiba-Falek O
    Bioinformatics strategy to advance the interpretation of Alzheimer's disease GWAS discoveries: The roads from association to causation.
    Alzheimers Dement. 2019 Jun 28. pii: S1552-5260(19)30121.
    PubMed     Abstract available

  80. LI H, Habes M, Wolk DA, Fan Y, et al
    A deep learning model for early prediction of Alzheimer's disease dementia based on hippocampal magnetic resonance imaging data.
    Alzheimers Dement. 2019 Jun 11. pii: S1552-5260(19)30086.
    PubMed     Abstract available

  81. STRANDBERG TE, Tienari PJ
    Contributions of vascular and Alzheimer's disease pathology to dementia.
    Alzheimers Dement. 2019 Jun 11. pii: S1552-5260(19)30108.

  82. MIRON J, Picard C, Lafaille-Magnan ME, Savard M, et al
    Association of TLR4 with Alzheimer's disease risk and presymptomatic biomarkers of inflammation.
    Alzheimers Dement. 2019 Jun 4. pii: S1552-5260(19)30087.
    PubMed     Abstract available

  83. VERMUNT L, Sikkes SAM, van den Hout A, Handels R, et al
    Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype.
    Alzheimers Dement. 2019 Jun 1. pii: S1552-5260(19)30084.
    PubMed     Abstract available

    May 2019
  84. CHIESA PA, Cavedo E, Vergallo A, Lista S, et al
    Differential default mode network trajectories in asymptomatic individuals at risk for Alzheimer's disease.
    Alzheimers Dement. 2019 May 18. pii: S1552-5260(19)30077.
    PubMed     Abstract available

  85. VERGALLO A, Megret L, Lista S, Cavedo E, et al
    Plasma amyloid beta 40/42 ratio predicts cerebral amyloidosis in cognitively normal individuals at risk for Alzheimer's disease.
    Alzheimers Dement. 2019 May 18. pii: S1552-5260(19)30082.
    PubMed     Abstract available

  86. RODRIGUEZ-GOMEZ O, Rodrigo A, Iradier F, Santos-Santos MA, et al
    The MOPEAD project: Advancing patient engagement for the detection of "hidden" undiagnosed cases of Alzheimer's disease in the community.
    Alzheimers Dement. 2019 May 6. pii: S1552-5260(19)30072.
    PubMed     Abstract available

  87. Erratum to "Kallikrein-8 inhibition attenuates Alzheimer's disease pathology in mice" [Alzheimer's & Dementia 2016;12:1273-87.].
    Alzheimers Dement. 2019 May 4. pii: S1552-5260(19)30117.

  88. SCHEEPERS LEJM, Jacobsson LTH, Kern S, Johansson L, et al
    Urate and risk of Alzheimer's disease and vascular dementia: A population-based study.
    Alzheimers Dement. 2019 May 2. pii: S1552-5260(19)30046.
    PubMed     Abstract available

    April 2019
  89. MORGAN AR, Touchard S, Leckey C, O'Hagan C, et al
    Inflammatory biomarkers in Alzheimer's disease plasma.
    Alzheimers Dement. 2019 Apr 29. pii: S1552-5260(19)30078.
    PubMed     Abstract available

  90. KIM M, Snowden S, Suvitaival T, Ali A, et al
    Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort.
    Alzheimers Dement. 2019 Apr 28. pii: S1552-5260(19)30074.
    PubMed     Abstract available

  91. WOO BKP, Chung S, Woo G, Chung JOP, et al
    Mitigating stigma of Alzheimer's disease dementia among Chinese Americans.
    Alzheimers Dement. 2019 Apr 25. pii: S1552-5260(19)30079.

    Aaron Klug and the study of Alzheimer's disease.
    Alzheimers Dement. 2019 Apr 19. pii: S1552-5260(19)30054.

  93. LLEO A, Alcolea D, Martinez-Lage P, Scheltens P, et al
    Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD study.
    Alzheimers Dement. 2019 Apr 6. pii: S1552-5260(19)30047.
    PubMed     Abstract available

    March 2019
  94. BIHLMEYER NA, Merrill E, Lambert Y, Srivastava GP, et al
    Novel methods for integration and visualization of genomics and genetics data in Alzheimer's disease.
    Alzheimers Dement. 2019 Mar 29. pii: S1552-5260(19)30032.
    PubMed     Abstract available

  95. Erratum to "Altered bile acid profile associates with cognitive impairment in Alzheimer's disease-An emerging role for gut microbiome" [Alzheimer's & Dementia 2019;15:76-92.].
    Alzheimers Dement. 2019 Mar 21. pii: S1552-5260(19)30055.

  96. KOUNTOURAS J, Doulberis M, Polyzos SA, Katsinelos T, et al
    Impact of Helicobacter pylori and/or Helicobacter pylori-related metabolic syndrome on incidence of all-cause and Alzheimer's dementia.
    Alzheimers Dement. 2019 Mar 11. pii: S1552-5260(19)30029.

  97. WHITWELL JL, Martin P, Graff-Radford J, Machulda MM, et al
    The role of age on tau PET uptake and gray matter atrophy in atypical Alzheimer's disease.
    Alzheimers Dement. 2019 Mar 7. pii: S1552-5260(19)30010.
    PubMed     Abstract available

  98. BOS I, Vos S, Verhey F, Scheltens P, et al
    Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum.
    Alzheimers Dement. 2019 Mar 7. pii: S1552-5260(19)30018.
    PubMed     Abstract available

    Primary age-related tauopathy (PART) and Alzheimer's disease (AD).
    Alzheimers Dement. 2019 Mar 7. pii: S1552-5260(19)30019.

  100. SUGARMAN MA, McKee AC, Stein TD, Tripodis Y, et al
    Failure to detect an association between self-reported traumatic brain injury and Alzheimer's disease neuropathology and dementia.
    Alzheimers Dement. 2019 Mar 6. pii: S1552-5260(19)30009.
    PubMed     Abstract available

  101. SCHINDLER SE, Li Y, Todd KW, Herries EM, et al
    Emerging cerebrospinal fluid biomarkers in autosomal dominant Alzheimer's disease.
    Alzheimers Dement. 2019 Mar 4. pii: S1552-5260(19)30013.
    PubMed     Abstract available

    February 2019
  102. GUTIERREZ J, Guzman V, Khasiyev F, Manly J, et al
    Brain arterial dilatation and the risk of Alzheimer's disease.
    Alzheimers Dement. 2019 Feb 28. pii: S1552-5260(19)30012.
    PubMed     Abstract available

    Parkinsonism in MCI or mild Alzheimer's disease.
    Alzheimers Dement. 2019 Feb 28. pii: S1552-5260(19)30002.

  104. ZHANG F, Zhong R, Li S, Fu Z, et al
    Alteration in sleep architecture and electroencephalogram as an early sign of Alzheimer's disease preceding the disease pathology and cognitive decline.
    Alzheimers Dement. 2019 Feb 25. pii: S1552-5260(18)33621.
    PubMed     Abstract available

  105. WANG G, Coble D, McDade EM, Hassenstab J, et al
    Staging biomarkers in preclinical autosomal dominant Alzheimer's disease by estimated years to symptom onset.
    Alzheimers Dement. 2019 Feb 14. pii: S1552-5260(18)33625.
    PubMed     Abstract available

  106. SANTOS OA, Pedraza O, Lucas JA, Duara R, et al
    Ethnoracial differences in Alzheimer's disease from the FLorida Autopsied Multi-Ethnic (FLAME) cohort.
    Alzheimers Dement. 2019 Feb 12. pii: S1552-5260(18)33630.
    PubMed     Abstract available

  107. ROGALSKI EJ, Sridhar J, Martersteck A, Rader B, et al
    Clinical and cortical decline in the aphasic variant of Alzheimer's disease.
    Alzheimers Dement. 2019 Feb 11. pii: S1552-5260(18)33620.
    PubMed     Abstract available

  108. LANGBAUM JB, Karlawish J, Roberts JS, Wood EM, et al
    GeneMatch: A novel recruitment registry using at-home APOE genotyping to enhance referrals to Alzheimer's prevention studies.
    Alzheimers Dement. 2019 Feb 6. pii: S1552-5260(18)33624.
    PubMed     Abstract available

  109. Erratum to "Blood-brain barrier breakdown, neuroinflammation, and cognitive decline in older adults" [Alzheimer's & Dementia 2018;14:1640-50.].
    Alzheimers Dement. 2019;15:319.

  110. Erratum to "Circulating metabolites and general cognitive ability and dementia: Evidence from 11 cohort studies" [Alzheimer's & Dementia 2018;14:707-22.].
    Alzheimers Dement. 2019;15:319.

    January 2019
  111. WOSTYN P, Van Dam D, De Deyn PP
    Alzheimer's disease and glaucoma: Look-alike neurodegenerative diseases.
    Alzheimers Dement. 2019 Jan 31. pii: S1552-5260(18)33629.

  112. MATTSSON N, Insel PS, Donohue M, Jogi J, et al
    Predicting diagnosis and cognition with (18)F-AV-1451 tau PET and structural MRI in Alzheimer's disease.
    Alzheimers Dement. 2019 Jan 9. pii: S1552-5260(18)33605.
    PubMed     Abstract available

  113. THOMAS KR, Eppig JS, Weigand AJ, Edmonds EC, et al
    Artificially low mild cognitive impairment to normal reversion rate in Alzheimer's Disease Neuroimaging Initiative.
    Alzheimers Dement. 2019 Jan 2. pii: S1552-5260(18)33603.
    PubMed     Abstract available

  114. MCCLEERY J, Flicker L, Richard E, Quinn TJ, et al
    The National Institute on Aging and Alzheimer's Association research framework: A commentary from the Cochrane Dementia and Cognitive Improvement Group.
    Alzheimers Dement. 2019;15:179-181.

  115. SWEENEY MD, Montagne A, Sagare AP, Nation DA, et al
    Vascular dysfunction-The disregarded partner of Alzheimer's disease.
    Alzheimers Dement. 2019;15:158-167.
    PubMed     Abstract available

  116. JAGUST W, Jack CR Jr, Bennett DA, Blennow K, et al
    "Alzheimer's disease" is neither "Alzheimer's clinical syndrome" nor "dementia".
    Alzheimers Dement. 2019;15:153-157.

  117. LOUIE R
    The 2018 NIA-AA research framework: Recommendation and comments.
    Alzheimers Dement. 2019;15:182-183.

  118. ALTIMUS CM, Keller K, Brannelly P, Ross E, et al
    Analysis of tauopathy research funding between 2006 and 2016 reveals critical gaps in research priorities.
    Alzheimers Dement. 2019;15:42-54.
    PubMed     Abstract available

    December 2018
  119. SLOT RER, Sikkes SAM, Berkhof J, Brodaty H, et al
    Subjective cognitive decline and rates of incident Alzheimer's disease and non-Alzheimer's disease dementia.
    Alzheimers Dement. 2018 Dec 13. pii: S1552-5260(18)33563.
    PubMed     Abstract available

  120. BABULAL GM, Quiroz YT, Albensi BC, Arenaza-Urquijo E, et al
    Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: Update and areas of immediate need.
    Alzheimers Dement. 2018 Dec 13. pii: S1552-5260(18)33556.
    PubMed     Abstract available

    November 2018
  121. ZHANG X, Zhu C, Beecham G, Vardarajan BN, et al
    A rare missense variant of CASP7 is associated with familial late-onset Alzheimer's disease.
    Alzheimers Dement. 2018 Nov 29. pii: S1552-5260(18)33579.
    PubMed     Abstract available

  122. XIONG F, Ge W, Ma C
    Quantitative proteomics reveals distinct composition of amyloid plaques in Alzheimer's disease.
    Alzheimers Dement. 2018 Nov 28. pii: S1552-5260(18)33580.
    PubMed     Abstract available

  123. BELL WR, An Y, Kageyama Y, English C, et al
    Neuropathologic, genetic, and longitudinal cognitive profiles in primary age-related tauopathy and Alzheimer's disease.
    Alzheimers Dement. 2018 Nov 19. pii: S1552-5260(18)33483.
    PubMed     Abstract available

  124. LATIMER CS, Shively CA, Keene CD, Jorgensen MJ, et al
    A nonhuman primate model of early Alzheimer's disease pathologic change: Implications for disease pathogenesis.
    Alzheimers Dement. 2018 Nov 19. pii: S1552-5260(18)33246.
    PubMed     Abstract available

  125. STARTIN CM, Hamburg S, Hithersay R, Al-Janabi T, et al
    Cognitive markers of preclinical and prodromal Alzheimer's disease in Down syndrome.
    Alzheimers Dement. 2018 Nov 15. pii: S1552-5260(18)33518.
    PubMed     Abstract available

  126. CHEN Z, Mengel D, Keshavan A, Rissman RA, et al
    Learnings about the complexity of extracellular tau aid development of a blood-based screen for Alzheimer's disease.
    Alzheimers Dement. 2018 Nov 9. pii: S1552-5260(18)33561.
    PubMed     Abstract available

  127. ISAACSON RS, Ganzer CA, Hristov H, Hackett K, et al
    The clinical practice of risk reduction for Alzheimer's disease: A precision medicine approach.
    Alzheimers Dement. 2018 Nov 5. pii: S1552-5260(18)33513.
    PubMed     Abstract available

    October 2018
  128. PALMQVIST S, Insel PS, Zetterberg H, Blennow K, et al
    Accurate risk estimation of beta-amyloid positivity to identify prodromal Alzheimer's disease: Cross-validation study of practical algorithms.
    Alzheimers Dement. 2018 Oct 23. pii: S1552-5260(18)33524.
    PubMed     Abstract available

  129. JOIE R, Ayakta N, Seeley WW, Borys E, et al
    Multisite study of the relationships between antemortem [(11)C]PIB-PET Centiloid values and postmortem measures of Alzheimer's disease neuropathology.
    Alzheimers Dement. 2018 Oct 19. pii: S1552-5260(18)33523.
    PubMed     Abstract available

  130. NHO K, Kueider-Paisley A, MahmoudianDehkordi S, Arnold M, et al
    Altered bile acid profile in mild cognitive impairment and Alzheimer's disease: Relationship to neuroimaging and CSF biomarkers.
    Alzheimers Dement. 2018 Oct 15. pii: S1552-5260(18)33521.
    PubMed     Abstract available

  131. HU X, Teunissen C, Spottke A, Heneka MT, et al
    Smaller medial temporal lobe volumes in individuals with subjective cognitive decline and biomarker evidence of Alzheimer's disease-Data from three memory clinic studies.
    Alzheimers Dement. 2018 Oct 12. pii: S1552-5260(18)33527.
    PubMed     Abstract available

  132. VEITCH DP, Weiner MW, Aisen PS, Beckett LA, et al
    Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative.
    Alzheimers Dement. 2018 Oct 12. pii: S1552-5260(18)33514.
    PubMed     Abstract available

  133. HUANG F, Wang M, Liu R, Wang JZ, et al
    CDT2-controlled cell cycle reentry regulates the pathogenesis of Alzheimer's disease.
    Alzheimers Dement. 2018 Oct 12. pii: S1552-5260(18)33522.
    PubMed     Abstract available

  134. SANDELIUS A, Portelius E, Kallen A, Zetterberg H, et al
    Elevated CSF GAP-43 is Alzheimer's disease specific and associated with tau and amyloid pathology.
    Alzheimers Dement. 2018 Oct 12. pii: S1552-5260(18)33515.
    PubMed     Abstract available

  135. MOIR RD, Lathe R, Tanzi RE
    The antimicrobial protection hypothesis of Alzheimer's disease.
    Alzheimers Dement. 2018 Oct 9. pii: S1552-5260(18)33228.
    PubMed     Abstract available

  136. MAHMOUDIANDEHKORDI S, Arnold M, Nho K, Ahmad S, et al
    Altered bile acid profile associates with cognitive impairment in Alzheimer's disease-An emerging role for gut microbiome.
    Alzheimers Dement. 2018 Oct 8. pii: S1552-5260(18)33486.
    PubMed     Abstract available

  137. SHAW LM, Arias J, Blennow K, Galasko D, et al
    Appropriate use criteria for lumbar puncture and cerebrospinal fluid testing in the diagnosis of Alzheimer's disease.
    Alzheimers Dement. 2018 Oct 3. pii: S1552-5260(18)33492.
    PubMed     Abstract available

  138. KODIS EJ, Choi S, Swanson E, Ferreira G, et al
    N-methyl-D-aspartate receptor-mediated calcium influx connects amyloid-beta oligomers to ectopic neuronal cell cycle reentry in Alzheimer's disease.
    Alzheimers Dement. 2018;14:1302-1312.
    PubMed     Abstract available

    September 2018
  139. MULLER S, Preische O, Sohrabi HR, Graber S, et al
    Relationship between physical activity, cognition, and Alzheimer pathology in autosomal dominant Alzheimer's disease.
    Alzheimers Dement. 2018 Sep 21. pii: S1552-5260(18)33248.
    PubMed     Abstract available

  140. RASMUSSEN KL, Nordestgaard BG, Frikke-Schmidt R, Nielsen SF, et al
    An updated Alzheimer hypothesis: Complement C3 and risk of Alzheimer's disease-A cohort study of 95,442 individuals.
    Alzheimers Dement. 2018 Sep 19. pii: S1552-5260(18)33496.
    PubMed     Abstract available

  141. LIN YF, Smith AV, Aspelund T, Betensky RA, et al
    Genetic overlap between vascular pathologies and Alzheimer's dementia and potential causal mechanisms.
    Alzheimers Dement. 2018 Sep 18. pii: S1552-5260(18)33493.
    PubMed     Abstract available

  142. MATTHEWS KA, Xu W, Gaglioti AH, Holt JB, et al
    Racial and ethnic estimates of Alzheimer's disease and related dementias in the United States (2015-2060) in adults aged >/=65 years.
    Alzheimers Dement. 2018 Sep 17. pii: S1552-5260(18)33252.
    PubMed     Abstract available

  143. SASAKI S
    High prevalence of parkinsonism in patients with MCI or mild Alzheimer's disease.
    Alzheimers Dement. 2018 Sep 14. pii: S1552-5260(18)33243.
    PubMed     Abstract available

  144. RAJAN KB, Weuve J, Barnes LL, Wilson RS, et al
    Prevalence and incidence of clinically diagnosed Alzheimer's disease dementia from 1994 to 2012 in a population study.
    Alzheimers Dement. 2018 Sep 6. pii: S1552-5260(18)33484.
    PubMed     Abstract available

  145. CAVEDO E, Chiesa PA, Houot M, Ferretti MT, et al
    Sex differences in functional and molecular neuroimaging biomarkers of Alzheimer's disease in cognitively normal older adults with subjective memory complaints.
    Alzheimers Dement. 2018;14:1204-1215.
    PubMed     Abstract available

  146. BEYDOUN MA, Beydoun HA, Elbejjani M, Dore GA, et al
    Helicobacter pylori seropositivity and its association with incident all-cause and Alzheimer's disease dementia in large national surveys.
    Alzheimers Dement. 2018;14:1148-1158.
    PubMed     Abstract available

  147. MIELKE MM, Ferretti MT, Iulita MF, Hayden K, et al
    Sex and gender in Alzheimer's disease - Does it matter?
    Alzheimers Dement. 2018;14:1101-1103.

    August 2018
  148. NICOLAS G, Acuna-Hidalgo R, Keogh MJ, Quenez O, et al
    Somatic variants in autosomal dominant genes are a rare cause of sporadic Alzheimer's disease.
    Alzheimers Dement. 2018 Aug 13. pii: S1552-5260(18)33245.
    PubMed     Abstract available

  149. TANG Y, Lutz MW, Xing Y
    A systems-based model of Alzheimer's disease.
    Alzheimers Dement. 2018 Aug 10. pii: S1552-5260(18)33247.
    PubMed     Abstract available

  150. LEE CS, Larson EB, Gibbons LE, Lee AY, et al
    Associations between recent and established ophthalmic conditions and risk of Alzheimer's disease.
    Alzheimers Dement. 2018 Aug 2. pii: S1552-5260(18)33034.
    PubMed     Abstract available

    July 2018
  151. VERGALLO A, Bun RS, Toschi N, Baldacci F, et al
    Association of cerebrospinal fluid alpha-synuclein with total and phospho-tau181 protein concentrations and brain amyloid load in cognitively normal subjective memory complainers stratified by Alzheimer's disease biomarkers.
    Alzheimers Dement. 2018 Jul 25. pii: S1552-5260(18)33241.
    PubMed     Abstract available

    June 2018
  152. RUTHIRAKUHAN M, Lanctot KL, Di Scipio M, Ahmed M, et al
    Biomarkers of agitation and aggression in Alzheimer's disease: A systematic review.
    Alzheimers Dement. 2018 Jun 22. pii: S1552-5260(18)30157.
    PubMed     Abstract available

  153. HANSSON O, Mikulskis A, Fagan AM, Teunissen C, et al
    The impact of preanalytical variables on measuring cerebrospinal fluid biomarkers for Alzheimer's disease diagnosis: A review.
    Alzheimers Dement. 2018 Jun 22. pii: S1552-5260(18)30162.
    PubMed     Abstract available

  154. YOO HS, Jeon S, Chung SJ, Evans AC, et al
    Olfactory dysfunction in Alzheimer's disease- and Lewy body-related cognitive impairment.
    Alzheimers Dement. 2018 Jun 21. pii: S1552-5260(18)30164.
    PubMed     Abstract available

    The National Institute on Aging-Alzheimer's Association Framework on Alzheimer's disease: Application to clinical trials.
    Alzheimers Dement. 2018 Jun 21. pii: S1552-5260(18)30160.
    PubMed     Abstract available

    May 2018
  156. NEBEL RA, Aggarwal NT, Barnes LL, Gallagher A, et al
    Understanding the impact of sex and gender in Alzheimer's disease: A call to action.
    Alzheimers Dement. 2018 May 31. pii: S1552-5260(18)30130.
    PubMed     Abstract available

  157. KHACHATURIAN AS, Hayden KM, Mielke MM, Tang Y, et al
    New thinking about thinking, part two. Theoretical articles for Alzheimer's & Dementia.
    Alzheimers Dement. 2018 May 26. pii: S1552-5260(18)30155.

  158. BUCKLEY RF, Mormino EC, Amariglio RE, Properzi MJ, et al
    Sex, amyloid, and APOE epsilon4 and risk of cognitive decline in preclinical Alzheimer's disease: Findings from three well-characterized cohorts.
    Alzheimers Dement. 2018 May 24. pii: S1552-5260(18)30132.
    PubMed     Abstract available

  159. TEIPEL SJ, Cavedo E, Lista S, Habert MO, et al
    Effect of Alzheimer's disease risk and protective factors on cognitive trajectories in subjective memory complainers.
    Alzheimers Dement. 2018 May 21. pii: S1552-5260(18)30126.
    PubMed     Abstract available

  160. JOHANSSON JU, Brubaker WD, Javitz H, Bergen AW, et al
    Peripheral complement interactions with amyloid beta peptide in Alzheimer's disease: Polymorphisms, structure, and function of complement receptor 1.
    Alzheimers Dement. 2018 May 21. pii: S1552-5260(18)30125.
    PubMed     Abstract available

  161. SAEED U, Mirza SS, MacIntosh BJ, Herrmann N, et al
    APOE-epsilon4 associates with hippocampal volume, learning, and memory across the spectrum of Alzheimer's disease and dementia with Lewy bodies.
    Alzheimers Dement. 2018 May 18. pii: S1552-5260(18)30127.
    PubMed     Abstract available

  162. IWATSUBO T, Iwata A, Suzuki K, Ihara R, et al
    Japanese and North American Alzheimer's Disease Neuroimaging Initiative studies: Harmonization for international trials.
    Alzheimers Dement. 2018 May 8. pii: S1552-5260(18)30102.
    PubMed     Abstract available

  163. BROOKMEYER R, Abdalla N
    Estimation of lifetime risks of Alzheimer's disease dementia using biomarkers for preclinical disease.
    Alzheimers Dement. 2018 May 7. pii: S1552-5260(18)30098.
    PubMed     Abstract available

  164. LI P, Yu L, Lim ASP, Buchman AS, et al
    Fractal regulation and incident Alzheimer's disease in elderly individuals.
    Alzheimers Dement. 2018 May 4. pii: S1552-5260(18)30108.
    PubMed     Abstract available

    April 2018
  165. MIELKE MM, Hagen CE, Xu J, Chai X, et al
    Plasma phospho-tau181 increases with Alzheimer's disease clinical severity and is associated with tau- and amyloid-positron emission tomography.
    Alzheimers Dement. 2018 Apr 4. pii: S1552-5260(18)30067.
    PubMed     Abstract available

  166. SILVERBERG N, Elliott C, Ryan L, Masliah E, et al
    NIA commentary on the NIA-AA Research Framework: Towards a biological definition of Alzheimer's disease.
    Alzheimers Dement. 2018;14:576-578.

  167. KNOPMAN DS, Haeberlein SB, Carrillo MC, Hendrix JA, et al
    The National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease: Perspectives from the Research Roundtable.
    Alzheimers Dement. 2018;14:563-575.
    PubMed     Abstract available

  168. JACK CR JR., Bennett DA, Blennow K, Carrillo MC, et al
    NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.
    Alzheimers Dement. 2018;14:535-562.
    PubMed     Abstract available

  169. KHACHATURIAN AS, Hayden KM, Mielke MM, Tang Y, et al
    Future prospects and challenges for Alzheimer's disease drug development in the era of the NIA-AA Research Framework.
    Alzheimers Dement. 2018;14:532-534.

    March 2018
  170. WHITWELL JL, Graff-Radford J, Tosakulwong N, Weigand SD, et al
    Imaging correlations of tau, amyloid, metabolism, and atrophy in typical and atypical Alzheimer's disease.
    Alzheimers Dement. 2018 Mar 29. pii: S1552-5260(18)30074.
    PubMed     Abstract available

  171. DARWEESH SKL, Wolters FJ, Ikram MA, de Wolf F, et al
    Inflammatory markers and the risk of dementia and Alzheimer's disease: A meta-analysis.
    Alzheimers Dement. 2018 Mar 29. pii: S1552-5260(18)30068.
    PubMed     Abstract available

  172. VERMUNT L, Veal CD, Meulen LT, Chrysostomou C, et al
    European Prevention of Alzheimer's Dementia Registry: Recruitment and prescreening approach for a longitudinal cohort and prevention trials.
    Alzheimers Dement. 2018 Mar 28. pii: S1552-5260(18)30064.
    PubMed     Abstract available

  173. SHI M, Tang L, Toledo JB, Ginghina C, et al
    Cerebrospinal fluid alpha-synuclein contributes to the differential diagnosis of Alzheimer's disease.
    Alzheimers Dement. 2018 Mar 28. pii: S1552-5260(18)30069.
    PubMed     Abstract available

  174. CACCIAGLIA R, Molinuevo JL, Falcon C, Brugulat-Serrat A, et al
    Effects of APOE-epsilon4 allele load on brain morphology in a cohort of middle-aged healthy individuals with enriched genetic risk for Alzheimer's disease.
    Alzheimers Dement. 2018 Mar 27. pii: S1552-5260(18)30044.
    PubMed     Abstract available

  175. MATTSSON N, Groot C, Jansen WJ, Landau S, et al
    Prevalence of the apolipoprotein E epsilon4 allele in amyloid beta positive subjects across the spectrum of Alzheimer's disease.
    Alzheimers Dement. 2018 Mar 27. pii: S1552-5260(18)30063.
    PubMed     Abstract available

  176. SUTPHEN CL, McCue L, Herries EM, Xiong C, et al
    Longitudinal decreases in multiple cerebrospinal fluid biomarkers of neuronal injury in symptomatic late onset Alzheimer's disease.
    Alzheimers Dement. 2018 Mar 23. pii: S1552-5260(18)30031.
    PubMed     Abstract available

  177. GOLDMAN DP, Fillit H, Neumann P
    Accelerating Alzheimer's disease drug innovations from the research pipeline to patients.
    Alzheimers Dement. 2018 Mar 23. pii: S1552-5260(18)30050.
    PubMed     Abstract available

  178. STITES SD, Rubright JD, Karlawish J
    What features of stigma do the public most commonly attribute to Alzheimer's disease dementia? Results of a survey of the U.S. general public.
    Alzheimers Dement. 2018 Mar 17. pii: S1552-5260(18)30025.
    PubMed     Abstract available

  179. SMITH RG, Hannon E, De Jager PL, Chibnik L, et al
    Elevated DNA methylation across a 48-kb region spanning the HOXA gene cluster is associated with Alzheimer's disease neuropathology.
    Alzheimers Dement. 2018 Mar 14. pii: S1552-5260(18)30049.
    PubMed     Abstract available

  180. CONNORS MH, Seeher KM, Crawford J, Ames D, et al
    The stability of neuropsychiatric subsyndromes in Alzheimer's disease.
    Alzheimers Dement. 2018 Mar 13. pii: S1552-5260(18)30048.
    PubMed     Abstract available

  181. CHIBA-FALEK O, Gottschalk WK, Lutz MW
    The effects of the TOMM40 poly-T alleles on Alzheimer's disease phenotypes.
    Alzheimers Dement. 2018 Mar 7. pii: S1552-5260(18)30043.
    PubMed     Abstract available

    February 2018
  182. TYNKKYNEN J, Chouraki V, van der Lee SJ, Hernesniemi J, et al
    Association of branched-chain amino acids and other circulating metabolites with risk of incident dementia and Alzheimer's disease: A prospective study in eight cohorts.
    Alzheimers Dement. 2018 Feb 28. pii: S1552-5260(18)30020.
    PubMed     Abstract available

  183. HANSSON O, Seibyl J, Stomrud E, Zetterberg H, et al
    CSF biomarkers of Alzheimer's disease concord with amyloid-beta PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts.
    Alzheimers Dement. 2018 Feb 27. pii: S1552-5260(18)30029.
    PubMed     Abstract available

  184. AHMAD S, Bannister C, van der Lee SJ, Vojinovic D, et al
    Disentangling the biological pathways involved in early features of Alzheimer's disease in the Rotterdam Study.
    Alzheimers Dement. 2018 Feb 26. pii: S1552-5260(18)30024.
    PubMed     Abstract available

  185. COHEN AD, McDade E, Christian B, Price J, et al
    Early striatal amyloid deposition distinguishes Down syndrome and autosomal dominant Alzheimer's disease from late-onset amyloid deposition.
    Alzheimers Dement. 2018 Feb 22. pii: S1552-5260(18)30019.
    PubMed     Abstract available

  186. HANON O, Vidal JS, Lehmann S, Bombois S, et al
    Plasma amyloid levels within the Alzheimer's process and correlations with central biomarkers.
    Alzheimers Dement. 2018 Feb 16. pii: S1552-5260(18)30021.
    PubMed     Abstract available

  187. KNOPMAN DS, Siemers ER, Bain LJ, Hendrix JA, et al
    National Institute on Aging - Alzheimer's Association Research Framework lays the groundwork for deeper understanding of Alzheimer's disease.
    Alzheimers Dement. 2018;14:261-262.

    January 2018
  188. MIRON J, Picard C, Nilsson N, Frappier J, et al
    CDK5RAP2 gene and tau pathophysiology in late-onset sporadic Alzheimer's disease.
    Alzheimers Dement. 2018 Jan 19. pii: S1552-5260(17)33875.
    PubMed     Abstract available

  189. DI GUARDO G
    Alzheimer's disease, cellular prion protein, and dolphins.
    Alzheimers Dement. 2018 Jan 15. pii: S1552-5260(17)33873.

  190. JIA J, Wei C, Chen S, Li F, et al
    The cost of Alzheimer's disease in China and re-estimation of costs worldwide.
    Alzheimers Dement. 2018 Jan 11. pii: S1552-5260(17)33877.
    PubMed     Abstract available

  191. HAMPEL H, Toschi N, Baldacci F, Zetterberg H, et al
    Alzheimer's disease biomarker-guided diagnostic workflow using the added value of six combined cerebrospinal fluid candidates: Abeta1-42, total-tau, phosphorylated-tau, NFL, neurogranin, and YKL-40.
    Alzheimers Dement. 2018 Jan 9. pii: S1552-5260(17)33872.
    PubMed     Abstract available

  192. TSE KH, Cheng A, Ma F, Herrup K, et al
    DNA damage-associated oligodendrocyte degeneration precedes amyloid pathology and contributes to Alzheimer's and dementia.
    Alzheimers Dement. 2018 Jan 9. pii: S1552-5260(17)33853.
    PubMed     Abstract available

  193. ACOSTA D, Powell F, Zhao Y, Raj A, et al
    Regional vulnerability in Alzheimer's: The role of cell-autonomous and transneuronal processes.
    Alzheimers Dement. 2018 Jan 4. pii: S1552-5260(17)33857.
    PubMed     Abstract available

  194. LI K, O'Brien R, Lutz M, Luo S, et al
    A prognostic model of Alzheimer's disease relying on multiple longitudinal measures and time-to-event data.
    Alzheimers Dement. 2018 Jan 3. pii: S1552-5260(17)33840.
    PubMed     Abstract available

    December 2017
  195. HALL H, Iulita MF, Gubert P, Aguilar LF, et al
    AF710B, an M1/sigma-1 receptor agonist with long-lasting disease-modifying properties in a transgenic rat model of Alzheimer's disease.
    Alzheimers Dement. 2017 Dec 29. pii: S1552-5260(17)33851.
    PubMed     Abstract available

  196. CHUNG J, Wang X, Maruyama T, Ma Y, et al
    Genome-wide association study of Alzheimer's disease endophenotypes at prediagnosis stages.
    Alzheimers Dement. 2017 Dec 20. pii: S1552-5260(17)33842.
    PubMed     Abstract available

  197. LEUZY A, Rodriguez-Vieitez E, Saint-Aubert L, Chiotis K, et al
    Longitudinal uncoupling of cerebral perfusion, glucose metabolism, and tau deposition in Alzheimer's disease.
    Alzheimers Dement. 2017 Dec 18. pii: S1552-5260(17)33844.
    PubMed     Abstract available

  198. BECKER RE, Kapogiannis D, Greig NH
    Does traumatic brain injury hold the key to the Alzheimer's puzzle?
    Alzheimers Dement. 2017 Dec 12. pii: S1552-5260(17)33843.
    PubMed     Abstract available

  199. PASPALAS CD, Carlyle BC, Leslie S, Preuss TM, et al
    The aged rhesus macaque manifests Braak stage III/IV Alzheimer's-like pathology.
    Alzheimers Dement. 2017 Dec 11. pii: S1552-5260(17)33841.
    PubMed     Abstract available

    November 2017
  200. BROOKMEYER R, Abdalla N, Kawas CH, Corrada MM, et al
    Forecasting the prevalence of preclinical and clinical Alzheimer's disease in the United States.
    Alzheimers Dement. 2017 Nov 29. pii: S1552-5260(17)33813.
    PubMed     Abstract available

  201. STEFANIAK JD, Su L, Mak E, Bahaei NS, et al
    Cerebral small vessel disease in middle age and genetic predisposition to late-onset Alzheimer's disease.
    Alzheimers Dement. 2017 Nov 18. pii: S1552-5260(17)33809.
    PubMed     Abstract available

  202. VIDONI ED, Bothwell RJ, Burns JM, Dwyer JR, et al
    Novel recruitment models will drive Alzheimer's trial success.
    Alzheimers Dement. 2017 Nov 17. pii: S1552-5260(17)33793.

    October 2017
  203. MONTAL V, Vilaplana E, Alcolea D, Pegueroles J, et al
    Cortical microstructural changes along the Alzheimer's disease continuum.
    Alzheimers Dement. 2017 Oct 31. pii: S1552-5260(17)33767.
    PubMed     Abstract available

  204. ALLEN M, Wang X, Burgess JD, Watzlawik J, et al
    Conserved brain myelination networks are altered in Alzheimer's and other neurodegenerative diseases.
    Alzheimers Dement. 2017 Oct 26. pii: S1552-5260(17)33766.
    PubMed     Abstract available

  205. CRANE PK, Foroud T, Montine TJ, Larson EB, et al
    Alzheimer's Disease Sequencing Project discovery and replication criteria for cases and controls: Data from a community-based prospective cohort study with autopsy follow-up.
    Alzheimers Dement. 2017 Oct 19. pii: S1552-5260(17)33764.
    PubMed     Abstract available

  206. AN Y, Varma VR, Varma S, Casanova R, et al
    Evidence for brain glucose dysregulation in Alzheimer's disease.
    Alzheimers Dement. 2017 Oct 19. pii: S1552-5260(17)33765.
    PubMed     Abstract available

  207. HAMPEL H, Mesulam MM, Cuello AC, Khachaturian AS, et al
    Revisiting the cholinergic hypothesis in Alzheimer's disease: Emerging evidence from translational and clinical research.
    Alzheimers Dement. 2017 Oct 10. pii: S1552-5260(17)33719.
    PubMed     Abstract available

    September 2017
  208. GUNN-MOORE D, Kaidanovich-Beilin O, Gallego Iradi MC, Gunn-Moore F, et al
    Alzheimer's disease in humans and other animals-A consequence of postreproductive life span and longevity rather than aging.
    Alzheimers Dement. 2017 Sep 30. pii: S1552-5260(17)33717.
    PubMed     Abstract available

  209. CRUCHAGA C, Del-Aguila JL, Saef B, Black K, et al
    Polygenic risk score of sporadic late-onset Alzheimer's disease reveals a shared architecture with the familial and early-onset forms.
    Alzheimers Dement. 2017 Sep 21. pii: S1552-5260(17)33708.
    PubMed     Abstract available

  210. XU M, Zhang DF, Luo R, Wu Y, et al
    A systematic integrated analysis of brain expression profiles reveals YAP1 and other prioritized hub genes as important upstream regulators in Alzheimer's disease.
    Alzheimers Dement. 2017 Sep 15. pii: S1552-5260(17)33707.
    PubMed     Abstract available

  211. GEERTS H, Hofmann-Apitius M, Anastasio TJ
    Knowledge-driven computational modeling in Alzheimer's research: Current state and future trends.
    Alzheimers Dement. 2017 Sep 14. pii: S1552-5260(17)33690.
    PubMed     Abstract available

  212. LIN PJ, Zhong Y, Fillit HM, Cohen JT, et al
    Hospitalizations for ambulatory care sensitive conditions and unplanned readmissions among Medicare beneficiaries with Alzheimer's disease.
    Alzheimers Dement. 2017 Sep 5. pii: S1552-5260(17)33687.
    PubMed     Abstract available

    August 2017
  213. KNOPMAN D, Alford E, Tate K, Long M, et al
    Patients come from populations and populations contain patients. A two-stage scientific and ethics review: The next adaptation for single institutional review boards.
    Alzheimers Dement. 2017;13:940-946.
    PubMed     Abstract available

  214. WOLF D, Bocchetta M, Preboske GM, Boccardi M, et al
    Reference standard space hippocampus labels according to the European Alzheimer's Disease Consortium-Alzheimer's Disease Neuroimaging Initiative harmonized protocol: Utility in automated volumetry.
    Alzheimers Dement. 2017;13:893-902.
    PubMed     Abstract available

  215. GRILL JD, Cox CG, Kremen S, Mendez MF, et al
    Patient and caregiver reactions to clinical amyloid imaging.
    Alzheimers Dement. 2017;13:924-932.
    PubMed     Abstract available

    July 2017
  216. CRANE A, Brubaker WD, Johansson JU, Trigunaite A, et al
    Peripheral complement interactions with amyloid beta peptide in Alzheimer's disease: 2. Relationship to Abeta immunotherapy.
    Alzheimers Dement. 2017 Jul 26. pii: S1552-5260(17)32898.
    PubMed     Abstract available

  217. LUTSEY PL, Misialek JR, Mosley TH, Gottesman RF, et al
    Sleep characteristics and risk of dementia and Alzheimer's disease: The Atherosclerosis Risk in Communities Study.
    Alzheimers Dement. 2017 Jul 21. pii: S1552-5260(17)32522.
    PubMed     Abstract available

  218. KINNUNEN KM, Cash DM, Poole T, Frost C, et al
    Presymptomatic atrophy in autosomal dominant Alzheimer's disease: A serial MRI study.
    Alzheimers Dement. 2017 Jul 21. pii: S1552-5260(17)32521.
    PubMed     Abstract available

  219. FRAIN L, Swanson D, Cho K, Gagnon D, et al
    Association of cancer and Alzheimer's disease risk in a national cohort of veterans.
    Alzheimers Dement. 2017 Jul 12. pii: S1552-5260(17)30218.
    PubMed     Abstract available

  220. BURGGREN AC, Mahmood Z, Harrison TM, Siddarth P, et al
    Hippocampal thinning linked to longer TOMM40 poly-T variant lengths in the absence of the APOE epsilon4 variant.
    Alzheimers Dement. 2017;13:739-748.
    PubMed     Abstract available

    June 2017
  221. CRANE PK, Trittschuh E, Mukherjee S, Saykin AJ, et al
    Incidence of cognitively defined late-onset Alzheimer's dementia subgroups from a prospective cohort study.
    Alzheimers Dement. 2017 Jun 14. pii: S1552-5260(17)30216.
    PubMed     Abstract available

  222. DRACHMAN DA, Smith TW, Alkamachi B, Kane K, et al
    Microvascular changes in Down syndrome with Alzheimer-type pathology: Insights into a potential vascular mechanism for Down syndrome and Alzheimer's disease.
    Alzheimers Dement. 2017 Jun 13. pii: S1552-5260(17)30219.
    PubMed     Abstract available

  223. CHOURAKI V, Preis SR, Yang Q, Beiser A, et al
    Association of amine biomarkers with incident dementia and Alzheimer's disease in the Framingham Study.
    Alzheimers Dement. 2017 Jun 8. pii: S1552-5260(17)30200.
    PubMed     Abstract available

  224. TOLPPANEN AM, Taipale H, Hartikainen S
    Head or brain injuries and Alzheimer's disease: A nested case-control register study.
    Alzheimers Dement. 2017 Jun 6. pii: S1552-5260(17)30201.
    PubMed     Abstract available

  225. PASCOAL TA, Mathotaarachchi S, Shin M, Benedet AL, et al
    Synergistic interaction between amyloid and tau predicts the progression to dementia.
    Alzheimers Dement. 2017;13:644-653.
    PubMed     Abstract available

  226. BRENOWITZ WD, Hubbard RA, Keene CD, Hawes SE, et al
    Mixed neuropathologies and estimated rates of clinical progression in a large autopsy sample.
    Alzheimers Dement. 2017;13:654-662.
    PubMed     Abstract available

  227. SCHELLE J, Hasler LM, Gopfert JC, Joos TO, et al
    Prevention of tau increase in cerebrospinal fluid of APP transgenic mice suggests downstream effect of BACE1 inhibition.
    Alzheimers Dement. 2017;13:701-709.
    PubMed     Abstract available

    May 2017
  228. BROWN BM, Sohrabi HR, Taddei K, Gardener SL, et al
    Habitual exercise levels are associated with cerebral amyloid load in presymptomatic autosomal dominant Alzheimer's disease.
    Alzheimers Dement. 2017 May 11. pii: S1552-5260(17)30147.
    PubMed     Abstract available

  229. WILLETTE AA, Webb JL, Lutz MW, Bendlin BB, et al
    Family history and TOMM40 '523 interactive associations with memory in middle-aged and Alzheimer's disease cohorts.
    Alzheimers Dement. 2017 May 10. pii: S1552-5260(17)30148.
    PubMed     Abstract available

  230. FEART C, Helmer C, Merle B, Herrmann FR, et al
    Associations of lower vitamin D concentrations with cognitive decline and long-term risk of dementia and Alzheimer's disease in older adults.
    Alzheimers Dement. 2017 May 9. pii: S1552-5260(17)30138.
    PubMed     Abstract available

  231. BRUBAKER WD, Crane A, Johansson JU, Yen K, et al
    Peripheral complement interactions with amyloid beta peptides in Alzheimer's disease: Erythrocyte clearance of amyloid beta peptides.
    Alzheimers Dement. 2017 May 2. pii: S1552-5260(17)30149.
    PubMed     Abstract available

    April 2017
  232. CARMONA-IRAGUI M, Balasa M, Benejam B, Alcolea D, et al
    Cerebral amyloid angiopathy in Down syndrome and sporadic and autosomal-dominant Alzheimer's disease.
    Alzheimers Dement. 2017 Apr 29. pii: S1552-5260(17)30146.
    PubMed     Abstract available

  233. CARRILLO MC, Fillit H, Ganguli M, Knopman D, et al
    Letter to the Editor re: Nexus of Cancer & Alzheimer's.
    Alzheimers Dement. 2017 Apr 19. pii: S1552-5260(17)30142.

  234. SCHELTENS NME, Tijms BM, Koene T, Barkhof F, et al
    Cognitive subtypes of probable Alzheimer's disease robustly identified in four cohorts.
    Alzheimers Dement. 2017 Apr 17. pii: S1552-5260(17)30137.
    PubMed     Abstract available

    March 2017
  235. RITCHIE K, Carriere I, Su L, O'Brien JT, et al
    The midlife cognitive profiles of adults at high risk of late-onset Alzheimer's disease: The PREVENT study.
    Alzheimers Dement. 2017 Mar 29. pii: S1552-5260(17)30093.
    PubMed     Abstract available

  236. NIELSEN RB, Egefjord L, Angleys H, Mouridsen K, et al
    Capillary dysfunction is associated with symptom severity and neurodegeneration in Alzheimer's disease.
    Alzheimers Dement. 2017 Mar 23. pii: S1552-5260(17)30092.
    PubMed     Abstract available

  237. WEINER MW, Veitch DP, Aisen PS, Beckett LA, et al
    Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials.
    Alzheimers Dement. 2017 Mar 22. pii: S1552-5260(16)33124.
    PubMed     Abstract available

  238. ROCKWOOD K, Howlett SE, Hoffman D, Schindler R, et al
    Clinical meaningfulness of Alzheimer's Disease Assessment Scale-Cognitive subscale change in relation to goal attainment in patients on cholinesterase inhibitors.
    Alzheimers Dement. 2017 Mar 21. pii: S1552-5260(17)30090.
    PubMed     Abstract available

  239. TOLEDO JB, Arnold M, Kastenmuller G, Chang R, et al
    Metabolic network failures in Alzheimer's disease-A biochemical road map.
    Alzheimers Dement. 2017 Mar 21. pii: S1552-5260(17)30046.
    PubMed     Abstract available

  240. KARLAWISH J, Jack CR Jr, Rocca WA, Snyder HM, et al
    Alzheimer's disease: The next frontier-Special Report 2017.
    Alzheimers Dement. 2017 Mar 14. pii: S1552-5260(17)30091.
    PubMed     Abstract available

  241. KARAGEORGIOU E, Vossel KA
    Brain rhythm attractor breakdown in Alzheimer's disease: Functional and pathologic implications.
    Alzheimers Dement. 2017 Mar 13. pii: S1552-5260(17)30061.
    PubMed     Abstract available

  242. PASE MP, Himali JJ, Jacques PF, DeCarli C, et al
    Sugary beverage intake and preclinical Alzheimer's disease in the community.
    Alzheimers Dement. 2017 Mar 5. pii: S1552-5260(17)30050.
    PubMed     Abstract available

  243. BALDACCI F, Toschi N, Lista S, Zetterberg H, et al
    Two-level diagnostic classification using cerebrospinal fluid YKL-40 in Alzheimer's disease.
    Alzheimers Dement. 2017 Mar 2. pii: S1552-5260(17)30047.
    PubMed     Abstract available

  244. BOSCO P, Redolfi A, Bocchetta M, Ferrari C, et al
    The impact of automated hippocampal volumetry on diagnostic confidence in patients with suspected Alzheimer's disease: An EADC study.
    Alzheimers Dement. 2017 Mar 2. pii: S1552-5260(17)30045.
    PubMed     Abstract available

  245. WEINTRAUB S, Randolph C, Bain L, Hendrix JA, et al
    Is cognitive decline measurable in preclinical Alzheimer's disease?
    Alzheimers Dement. 2017;13:322-323.

  246. HERUKKA SK, Simonsen AH, Andreasen N, Baldeiras I, et al
    Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairment.
    Alzheimers Dement. 2017;13:285-295.
    PubMed     Abstract available

  247. SIMONSEN AH, Herukka SK, Andreasen N, Baldeiras I, et al
    Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia.
    Alzheimers Dement. 2017;13:274-284.
    PubMed     Abstract available

  248. TON TGN, DeLeire T, May SG, Hou N, et al
    The financial burden and health care utilization patterns associated with amnestic mild cognitive impairment.
    Alzheimers Dement. 2017;13:217-224.
    PubMed     Abstract available

    February 2017
  249. MORMINO EC, Papp KV, Rentz DM, Donohue MC, et al
    Early and late change on the preclinical Alzheimer's cognitive composite in clinically normal older individuals with elevated beta-amyloid.
    Alzheimers Dement. 2017 Feb 27. pii: S1552-5260(17)30044.
    PubMed     Abstract available

  250. KIN WONG MW, Braidy N, Poljak A, Pickford R, et al
    Dysregulation of lipids in Alzheimer's disease and their role as potential biomarkers.
    Alzheimers Dement. 2017 Feb 24. pii: S1552-5260(17)30012.
    PubMed     Abstract available

  251. MUKHERJEE S, Russell JC, Carr DT, Burgess JD, et al
    Systems biology approach to late-onset Alzheimer's disease genome-wide association study identifies novel candidate genes validated using brain expression data and Caenorhabditis elegans experiments.
    Alzheimers Dement. 2017 Feb 24. pii: S1552-5260(17)30042.
    PubMed     Abstract available

  252. JIA J, Gauthier S, Pallotta S, Ji Y, et al
    Consensus-based recommendations for the management of rapid cognitive decline due to Alzheimer's disease.
    Alzheimers Dement. 2017 Feb 23. pii: S1552-5260(17)30011.
    PubMed     Abstract available

  253. JONSSON L, Lin PJ, Khachaturian AS
    Special topic section on health economics and public policy of Alzheimer's disease.
    Alzheimers Dement. 2017 Feb 20. pii: S1552-5260(17)30085.

  254. FARDO DW, Gibbons LE, Mukherjee S, Glymour MM, et al
    Impact of home visit capacity on genetic association studies of late-onset Alzheimer's disease.
    Alzheimers Dement. 2017 Feb 18. pii: S1552-5260(17)30018.
    PubMed     Abstract available

  255. TEICHMANN M, Epelbaum S, Samri D, Levy Nogueira M, et al
    Free and Cued Selective Reminding Test-accuracy for Alzheimer's and neurodegenerative disease differential diagnosis: A large-scale biomarker-characterized monocenter cohort study (ClinAD).
    Alzheimers Dement. 2017 Feb 18. pii: S1552-5260(17)30014.
    PubMed     Abstract available

  256. OBOUDIYAT C, Gefen T, Varelas E, Weintraub S, et al
    Cerebrospinal fluid markers detect Alzheimer's disease in nonamnestic dementia.
    Alzheimers Dement. 2017 Feb 11. pii: S1552-5260(17)30010.
    PubMed     Abstract available

  257. EPELBAUM S, Genthon R, Cavedo E, Habert MO, et al
    Preclinical Alzheimer's disease: A systematic review of the cohorts underlying the concept.
    Alzheimers Dement. 2017 Feb 7. pii: S1552-5260(16)33123.
    PubMed     Abstract available

  258. JUN GR, Chung J, Mez J, Barber R, et al
    Transethnic genome-wide scan identifies novel Alzheimer's disease loci.
    Alzheimers Dement. 2017 Feb 6. pii: S1552-5260(17)30003.
    PubMed     Abstract available

  259. SPOSATO LA, Ruiz Vargas E, Riccio PM, Toledo JB, et al
    Milder Alzheimer's disease pathology in heart failure and atrial fibrillation.
    Alzheimers Dement. 2017 Feb 4. pii: S1552-5260(16)33122.
    PubMed     Abstract available

  260. OVERK C, Masliah E
    Perspective on the calcium dyshomeostasis hypothesis in the pathogenesis of selective neuronal degeneration in animal models of Alzheimer's disease.
    Alzheimers Dement. 2017;13:183-185.

    January 2017
  261. NESTOR SM, Misic B, Ramirez J, Zhao J, et al
    Small vessel disease is linked to disrupted structural network covariance in Alzheimer's disease.
    Alzheimers Dement. 2017 Jan 27. pii: S1552-5260(16)33128.
    PubMed     Abstract available

  262. LLINAS R, Moreno H
    Perspective on calcium and Alzheimer disease.
    Alzheimers Dement. 2017 Jan 25. pii: S1552-5260(17)30008.

  263. LOVHEIM H, Elgh F, Johansson A, Zetterberg H, et al
    Plasma concentrations of free amyloid beta cannot predict the development of Alzheimer's disease.
    Alzheimers Dement. 2017 Jan 7. pii: S1552-5260(16)33125.
    PubMed     Abstract available

  264. ZHAO J, Zhu Y, Yang J, Li L, et al
    A genome-wide profiling of brain DNA hydroxymethylation in Alzheimer's disease.
    Alzheimers Dement. 2017 Jan 6. pii: S1552-5260(16)33059.
    PubMed     Abstract available

  265. GUSTAVSSON A, Green C, Jones RW, Forstl H, et al
    Current issues and future research priorities for health economic modelling across the full continuum of Alzheimer's disease.
    Alzheimers Dement. 2017 Jan 4. pii: S1552-5260(16)33126.
    PubMed     Abstract available

  266. Calcium Hypothesis of Alzheimer's disease and brain aging: A framework for integrating new evidence into a comprehensive theory of pathogenesis.
    Alzheimers Dement. 2017 Jan 3. pii: S1552-5260(16)33127.
    PubMed     Abstract available

    December 2016
  267. DODGE HH, Zhu J, Woltjer R, Nelson PT, et al
    Risk of incident clinical diagnosis of Alzheimer's disease-type dementia attributable to pathology-confirmed vascular disease.
    Alzheimers Dement. 2016 Dec 22. pii: S1552-5260(16)33091.
    PubMed     Abstract available

  268. SNYDER HM, Ahles T, Calderwood S, Carrillo MC, et al
    Exploring the nexus of Alzheimer's disease and related dementias with cancer and cancer therapies.
    Alzheimers Dement. 2016 Dec 17. pii: S1552-5260(16)33090.
    PubMed     Abstract available

  269. CARRASQUILLO MM, Allen M, Burgess JD, Wang X, et al
    A candidate regulatory variant at the TREM gene cluster associates with decreased Alzheimer's disease risk and increased TREML1 and TREM2 brain gene expression.
    Alzheimers Dement. 2016 Dec 8. pii: S1552-5260(16)33071.
    PubMed     Abstract available

  270. WEINER MW, Veitch DP, Aisen PS, Beckett LA, et al
    The Alzheimer's Disease Neuroimaging Initiative 3: Continued innovation for clinical trial improvement.
    Alzheimers Dement. 2016 Dec 5. pii: S1552-5260(16)33072.
    PubMed     Abstract available

    November 2016
  271. CRONIN P, McCarthy MJ, Lim AS, Salmon DP, et al
    Circadian alterations during early stages of Alzheimer's disease are associated with aberrant cycles of DNA methylation in BMAL1.
    Alzheimers Dement. 2016 Nov 21. pii: S1552-5260(16)33058.
    PubMed     Abstract available

  272. O'BRYANT SE, Mielke MM, Rissman RA, Lista S, et al
    Blood-based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic.
    Alzheimers Dement. 2016 Nov 18. pii: S1552-5260(16)33056.
    PubMed     Abstract available

  273. SNYDER HM, Shineman DW, Friedman LG, Hendrix JA, et al
    Guidelines to improve animal study design and reproducibility for Alzheimer's disease and related dementias: For funders and researchers.
    Alzheimers Dement. 2016;12:1177-1185.
    PubMed     Abstract available

  274. FARGO KN, Carrillo MC, Weiner MW, Potter WZ, et al
    The crisis in recruitment for clinical trials in Alzheimer's and dementia: An action plan for solutions.
    Alzheimers Dement. 2016;12:1113-1115.

    October 2016
  275. MASTROENI D, Khdour OM, Delvaux E, Nolz J, et al
    Nuclear but not mitochondrial-encoded OXPHOS genes are altered in aging, mild cognitive impairment, and Alzheimer's disease.
    Alzheimers Dement. 2016 Oct 25. pii: S1552-5260(16)32932.
    PubMed     Abstract available

  276. MEZ J, Chung J, Jun G, Kriegel J, et al
    Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.
    Alzheimers Dement. 2016 Oct 19. pii: S1552-5260(16)32931.
    PubMed     Abstract available

  277. HAMLETT ED, Goetzl EJ, Ledreux A, Vasilevko V, et al
    Neuronal exosomes reveal Alzheimer's disease biomarkers in Down syndrome.
    Alzheimers Dement. 2016 Oct 15. pii: S1552-5260(16)32892.
    PubMed     Abstract available

  278. LAM B, Khan A, Keith J, Rogaeva E, et al
    Characterizing familial corticobasal syndrome due to Alzheimer's pathology and PSEN1 mutations.
    Alzheimers Dement. 2016 Oct 12. pii: S1552-5260(16)32894.
    PubMed     Abstract available

  279. RITCHIE K, Ropacki M, Albala B, Harrison J, et al
    Recommended cognitive outcomes in preclinical Alzheimer's disease: Consensus statement from the European Prevention of Alzheimer's Dementia project.
    Alzheimers Dement. 2016 Oct 1. pii: S1552-5260(16)32902.
    PubMed     Abstract available

  280. MORTAMAIS M, Ash JA, Harrison J, Kaye J, et al
    Detecting cognitive changes in preclinical Alzheimer's disease: A review of its feasibility.
    Alzheimers Dement. 2016 Oct 1. pii: S1552-5260(16)32901.
    PubMed     Abstract available

    September 2016
  281. JACK CR, Wiste HJ, Weigand SD, Therneau TM, et al
    Defining imaging biomarker cut points for brain aging and Alzheimer's disease.
    Alzheimers Dement. 2016 Sep 30. pii: S1552-5260(16)32875.
    PubMed     Abstract available

  282. PEGUEROLES J, Vilaplana E, Montal V, Sampedro F, et al
    Longitudinal brain structural changes in preclinical Alzheimer disease.
    Alzheimers Dement. 2016 Sep 28. pii: S1552-5260(16)32890.
    PubMed     Abstract available

  283. NORAMBUENA A, Wallrabe H, McMahon L, Silva A, et al
    mTOR and neuronal cell cycle reentry: How impaired brain insulin signaling promotes Alzheimer's disease.
    Alzheimers Dement. 2016 Sep 28. pii: S1552-5260(16)32895.
    PubMed     Abstract available

  284. PROITSI P, Kim M, Whiley L, Simmons A, et al
    Association of blood lipids with Alzheimer's disease: A comprehensive lipidomics analysis.
    Alzheimers Dement. 2016 Sep 28. pii: S1552-5260(16)30022.
    PubMed     Abstract available

  285. LOVHEIM H, Elgh F, Johansson A, Zetterberg H, et al
    Plasma concentrations of free amyloid-beta cannot predict the development of Alzheimer's disease.
    Alzheimers Dement. 2016 Sep 28. pii: S1552-5260(16)32896.
    PubMed     Abstract available

  286. NI R, Gillberg PG, Bogdanovic N, Viitanen M, et al
    Amyloid tracers binding sites in autosomal dominant and sporadic Alzheimer's disease.
    Alzheimers Dement. 2016 Sep 28. pii: S1552-5260(16)30141.
    PubMed     Abstract available

  287. LEEUWIS AE, Benedictus MR, Kuijer JP, Binnewijzend MA, et al
    Lower cerebral blood flow is associated with impairment in multiple cognitive domains in Alzheimer's disease.
    Alzheimers Dement. 2016 Sep 27. pii: S1552-5260(16)32893.
    PubMed     Abstract available

  288. SNYDER HM, Asthana S, Bain L, Brinton R, et al
    Sex biology contributions to vulnerability to Alzheimer's disease: A think tank convened by the Women's Alzheimer's Research Initiative.
    Alzheimers Dement. 2016 Sep 21. pii: S1552-5260(16)32874.
    PubMed     Abstract available

    April 2016
  289. LIM YY, Maruff P, Getter C, Snyder PJ, et al
    Disclosure of positron emission tomography amyloid imaging results: A preliminary study of safety and tolerability.
    Alzheimers Dement. 2016;12:454-8.
    PubMed     Abstract available

  290. CRANE PK, Gibbons LE, McCurry SM, McCormick W, et al
    Importance of home study visit capacity in dementia studies.
    Alzheimers Dement. 2016;12:419-26.
    PubMed     Abstract available

    February 2016
  291. VERLINDEN VJ, van der Geest JN, de Bruijn RF, Hofman A, et al
    Trajectories of decline in cognition and daily functioning in preclinical dementia.
    Alzheimers Dement. 2016;12:144-53.
    PubMed     Abstract available

  292. TIWARI MK, Kepp KP
    beta-Amyloid pathogenesis: Chemical properties versus cellular levels.
    Alzheimers Dement. 2016;12:184-94.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.